Exact Mass: 431.0164
Exact Mass Matches: 431.0164
Found 51 metabolites which its exact mass value is equals to given mass value 431.0164
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rimsulfuron
CONFIDENCE standard compound; EAWAG_UCHEM_ID 130 EAWAG_UCHEM_ID 130; CONFIDENCE standard compound
4-Ketoanhydrochlortetracycline
Benzthiazide
Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue. C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
Pimasertib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Pimasertib (AS703026) is a highly selective, ATP non-competitive allosteric orally available MEK1/2 inhibitor[1][2].
[[(2r,3s,4r,5r)-5-(4-Azanyl-2-Oxidanylidene-Pyrimidin-1-Yl)-3,4-Bis(Oxidanyl)oxolan-2-Yl]methoxy-Oxidanyl-Phosphoryl]oxy-(2-Hydroxyethyl)phosphinic Acid
N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide
8-Acetamido-1,1,1,15,15-pentachloropentadeca-3,12-diyne
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
cyclopenta-1,3-diene,9H-fluoren-9-ide,propan-2-ylidenezirconium(2+),dichloride
5-bromo-4-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide
8-((6-BROMOBENZO[D][1,3]DIOXOL-5-YL)THIO)-9-(PENT-4-YN-1-YL)-9H-PURIN-6-AMINE
Thiazolidine, 2-(2-chlorophenyl)-3-[(4-phenoxyphenyl)sulfonyl]- (9CI)
TRANS-4-[2-(1-FERROCENYL)VINYL]-1-METHYLPYRIDINIUM IODIDE
2-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]benzoic acid, sodium salt
N-(2-CARBOXY-4,5-DICHLOROBENZOYL)-(-)-10,2-CAMPHORSULTAM
ETHYL [3-(4-BROMOPHENYL)-4,6-DIMETHOXY-1H-INDOL-7-YL]-OXO-ACETATE
(S)-1-(tert-Butoxycarbonyl)-2-(4-iodobenzyl)pyrrolidine-2-carboxylic acid
1-[4-BROMO-2-(HYDROXYMETHYL)PHENYL]-4-(DIMETHYLAMINO)-1-(4-FLUOROPHENYL) BUTAN-1-OL HYDROCHLORIDE
CYCLOPENTADIENYL(FLUORENE)IRON HEXAFLUOROPHOSPHATE
Acetic acid, 2-[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-, ethyl ester
Ferric Maltol
B - Blood and blood forming organs > B03 - Antianemic preparations > B03A - Iron preparations > B03AB - Iron trivalent, oral preparations D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds
[(1s)-1-(5-Chloro-1-Benzothien-3-Yl)-2-(2-Naphthylamino)-2-Oxoethyl]phosphonic Acid
N-[4-(2,5-dimethoxyphenyl)-2-thiazolyl]-2-[(4-nitrophenyl)thio]acetamide
2-(2,3-Dihydro-1,4-benzodioxin-6-ylsulfonylamino)benzoic acid thiophen-2-ylmethyl ester
N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-2-(trifluoromethyl)benzamide
(2S,3S,4S,5R)-6-[[3-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5-yl]amino]-3,4,5-trihydroxyoxane-2-carboxylic acid
benzthiazide
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
CMP-5-phosphonoformic acid
A cytidine 5-phosphate obtained by formal condensation of the phosphate group of CMP with the phosphono group of phosphonoformic acid.